Topic
Bacillus Calmette-Guérin (BCG)
17 Podcasts • 4 Courses on BackTable
Episode # 67 • 18 Jun 2026
Bladder Cancer Risk Stratification: Best Practices
Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate and high-risk patients? In this episode of BackTable, Dr. Bogdana Schmidt interviews urologists Dr. Kristen Scarpato and Dr. Sunil Patel to explore the complexities of diagnosis and risk assessment in non–muscle invasive bladder cancer (NMIBC). They discuss the real-world challenges of pathology interpretation, risk-group assignment, evolving diagnostic tools, and the impact these factors have on treatment decisions and patient outcomes.
This podcast is supported by an educational grant from Johnson & Johnson.
More on Bacillus Calmette-Guérin (BCG)
Loading recent podcasts…
Tumor Board # 67
Jun 17, 2026
with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt
Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...
Tumor Board # 63
Jun 3, 2026
with Dr. Amy Luckenbaugh, Meredith Donahue NP, Dr. Bogdana Schmidt
Are traditional bladder cancer care models falling behind as new therapies flood the field and reshape the landscape?...
Urology # 305
Jun 1, 2026
with Dr. Sam Chang, Dr. Ruchika Talwar
Ready to move beyond “one-size-fits-all” for BCG-unresponsive NMIBC? In this episode of BackTable Urology, Dr. Ruchika...
1,400+ listens
Urology # 271
Nov 6, 2025
with Dr. Katie Murray, Dr. Sarah Psutka, Dr. Vignesh Packiam
As new genetic and AI-powered tools emerge for bladder cancer screening, are we getting closer to reducing the need for...
1,400+ listens
Urology # 310
Jun 17, 2026
with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt
Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...
1,200+ listens
Urology # 306
Jun 3, 2026
with Dr. Amy Luckenbaugh, Meredith Donahue NP, Dr. Bogdana Schmidt
Are traditional bladder cancer care models falling behind as new therapies flood the field and reshape the landscape?...
Urology # 273
Nov 13, 2025
with Meredith Donahue NP, Brynn Moore RN, Dr. Ruchika Talwar
With the right protocols (and the right team!), urology clinics can proactively manage the side effects of intravesical...
1,100+ listens
Urology # 267
Oct 20, 2025
with Dr. Mark Tyson, Dr. Suzanne Merrill, Dr. Bogdana Schmidt
New FDA-approved therapies for BCG-refractory non-muscle invasive bladder cancer (NMIBC)–where do they fit in the...
1,400+ listens
Urology Course
3 hours, 28 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.